|
|
|
Volumn 26, Issue 3 SUPPL. 11, 1999, Pages 4-8
|
|
Overview of docetaxel (Taxotere) in the treatment of non-small cell lung cancer
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CORTICOSTEROID;
DOCETAXEL;
ADULT;
BONE MARROW SUPPRESSION;
CANCER SURVIVAL;
CLINICAL TRIAL;
CYTOTOXICITY;
DOSE RESPONSE;
EDEMA;
FEBRILE NEUTROPENIA;
FEMALE;
FLUID RETENTION;
HUMAN;
INTRAVENOUS DRUG ADMINISTRATION;
LUNG CANCER;
LUNG NON SMALL CELL CANCER;
MAJOR CLINICAL STUDY;
MALE;
META ANALYSIS;
PHASE 2 CLINICAL TRIAL;
PRIORITY JOURNAL;
REVIEW;
SURVIVAL RATE;
THROMBOCYTOPENIA;
ANTINEOPLASTIC AGENTS, PHYTOGENIC;
CARCINOMA, NON-SMALL-CELL LUNG;
CLINICAL TRIALS, PHASE II;
HUMANS;
LUNG NEOPLASMS;
PACLITAXEL;
TAXOIDS;
|
|
EID: 0032839721
PISSN: 00937754
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (6)
|
|
References (34)
|
